New Jersey · 2026-2027 Regular Session · Joint Resolution
AJR 161: Establishes New Jersey Pancreatic Cancer Commission.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
AJR 161 is a joint resolution introduced in the New Jersey House on March 16, 2026. According to its official title, it concerns: Establishes New Jersey Pancreatic Cancer Commission. Primary sponsor: Shanique Speight (Democratic), Donlon, Margie, M.D.. It lists 1 additional sponsor. Most recent recorded action (March 16, 2026): Introduced, Referred to Assembly Health Committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 1 · Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Shanique Speight | Primary sponsor | Democratic | House | 29 |
| Donlon, Margie, M.D. | Primary sponsor | Not applicable (committee) | — | — |
| Gerry Scharfenberger | Co-sponsor | Republican | House | 13 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Introduced, Referred to Assembly Health Committee